this presentation will talk about the classes of drugs that use in heart failure, discuss each class, their mechanism of action, adverse effects, pictures for easy understanding and at the end of the presentation contain mcq study question with answers.

1. PREPARED BY: MUHAMMAD KHOSHKANI

2. MUHAMMAD KHOSHKANI
2

3. MUHAMMAD KHOSHKANI
3
Review anatomy

4. I. OVERVIEW MUHAMMAD KHOSHKANI
4

5. I. OVERVIEW MUHAMMAD KHOSHKANI
5

6. MUHAMMAD KHOSHKANI
6

7. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
7

8. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
8

9. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
9

10. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
10

11. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
11

12. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
12

13. MUHAMMAD KHOSHKANI
13

14. MUHAMMAD KHOSHKANI
14

15. MUHAMMAD KHOSHKANI
15

16. MUHAMMAD KHOSHKANI
16

17. MUHAMMAD KHOSHKANI
17

18. MUHAMMAD KHOSHKANI
18

19. MUHAMMAD KHOSHKANI
19

20. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
20

21. II. PHYSIOLOGY OF MUSCLE CONTRACTION MUHAMMAD KHOSHKANI
21

22. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
22

23. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
23

24. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
24

25. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
25

26. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
26

27. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
27

28. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
28

29. III. INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM MUHAMMAD KHOSHKANI
29

30. IV. 𝜷 -BLOCKERS MUHAMMAD KHOSHKANI
30

31. IV. 𝜷 -BLOCKERS MUHAMMAD KHOSHKANI
31

32. MUHAMMAD KHOSHKANI
32

33. V. DIURETICS MUHAMMAD KHOSHKANI
33

34. VI. ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR MUHAMMAD KHOSHKANI
34

35. VI. ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR MUHAMMAD KHOSHKANI
35

36. VI. ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR MUHAMMAD KHOSHKANI
36

37. MUHAMMAD KHOSHKANI
37

38. VII. HYPERPOLARIZATION-ACTIVATED CYCLIC
NUCLEOTIDE-GATED CHANNEL BLOCKER
MUHAMMAD KHOSHKANI
38

39. MUHAMMAD KHOSHKANI
39

40. VII. HYPERPOLARIZATION-ACTIVATED CYCLIC
NUCLEOTIDE-GATED CHANNEL BLOCKER
MUHAMMAD KHOSHKANI
40

41. VII. HYPERPOLARIZATION-ACTIVATED CYCLIC
NUCLEOTIDE-GATED CHANNEL BLOCKER
MUHAMMAD KHOSHKANI
41

42. VIII. VASO - AND VENODILATORS MUHAMMAD KHOSHKANI
42

43. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
43

44. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
44

45. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
45

46. MUHAMMAD KHOSHKANI
46

47. MUHAMMAD KHOSHKANI
47

48. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
48

49. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
49

50. MUHAMMAD KHOSHKANI
50

51. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
51

52. MUHAMMAD KHOSHKANI
52

53. IX. INOTROPIC DRUGS MUHAMMAD KHOSHKANI
53

54. X. RECOMBINANT B-TYPE NATRIURETIC PEPTIDE MUHAMMAD KHOSHKANI
54

55. XI. ORDER OF THERAPY MUHAMMAD KHOSHKANI
55

56. MUHAMMAD KHOSHKANI
56

57. STUDY QUESTIONS MUHAMMAD KHOSHKANI
57

58. STUDY QUESTIONS MUHAMMAD KHOSHKANI
58

59. STUDY QUESTIONS MUHAMMAD KHOSHKANI
59

60. STUDY QUESTIONS MUHAMMAD KHOSHKANI
60

61. STUDY QUESTIONS MUHAMMAD KHOSHKANI
61

62. STUDY QUESTIONS MUHAMMAD KHOSHKANI
62

63. THANK YOU
‫مەکەن‬ ‫بەشامن‬ ‫بێ‬ ‫خێر‬ ‫دوعای‬ ‫لە‬
63